Needham Maintains Sight Sciences(SGHT.US) With Hold Rating
A Quick Look at Today's Ratings for Sight Sciences(SGHT.US), With a Forecast Between $2.5 to $4
Sight Sciences Analyst Ratings
Sight Sciences Is Maintained at Buy by Stifel
Piper Sandler Maintains Neutral on Sight Sciences, Lowers Price Target to $3.5
A Quick Look at Today's Ratings for Sight Sciences(SGHT.US), With a Forecast Between $3 to $4
Sight Sciences: Hold Rating Amid Revenue Challenges and Reimbursement Progress
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Envista Holdings (NVST) and Sight Sciences (SGHT)
Sight Sciences Analyst Ratings
Citigroup Maintains Neutral on Sight Sciences, Lowers Price Target to $3
Citi Maintains Sight Sciences(SGHT.US) With Hold Rating, Announces Target Price $3
Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT) and Teladoc (TDOC)
Citi Maintains Sight Sciences(SGHT.US) With Hold Rating
Stifel Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $5
Stifel Maintains Sight Sciences(SGHT.US) With Buy Rating, Announces Target Price $5
Sight Sciences Analyst Ratings
UBS Maintains Sight Sciences(SGHT.US) With Buy Rating, Cuts Target Price to $5
Morgan Stanley Maintains Sight Sciences(SGHT.US) With Hold Rating, Maintains Target Price $3
Morgan Stanley Maintains Sight Sciences(SGHT.US) With Hold Rating, Cuts Target Price to $3
Citi Maintains Sight Sciences(SGHT.US) With Hold Rating